miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
about
Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System ReviewSignaling of miRNAs-FOXM1 in cancer and potential targeted therapyGenome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinomaMicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancersTwist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1.MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasionDiagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion"TORNADO" - Theranostic One-Step RNA Detector; microfluidic disc for the direct detection of microRNA-134 in plasma and cerebrospinal fluidNon-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer.Whole DNA methylome profiling in lung cancer cells before and after epithelial-to-mesenchymal transition.Targeting miRNAs for pancreatic cancer therapyMiR-495 regulates proliferation and migration in NSCLC by targeting MTA3.miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cellsTongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factorUp-regulation of matrix metalloproteinases in a mouse model of chemically induced colitis-associated cancer: the role of microRNAs.miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity.Novel functions of FoxM1: from molecular mechanisms to cancer therapymiR-32 inhibits proliferation, epithelial-mesenchymal transition, and metastasis by targeting TWIST1 in non-small-cell lung cancer cellsEpithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signallingmiR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptorMiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathwayMiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse.Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1.MicroRNA-134 functions as a tumor suppressor gene in gastric cancerThe roles of FOXM1 in pancreatic stem cells and carcinogenesisPost-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.miR-134: A Human Cancer Suppressor?Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway.MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer.
P2860
Q26785676-F4F4C19F-DBC3-4C87-B3D6-24D4C92DF0EFQ26825764-3C9FEEC5-322E-4ED2-A34B-A234C98781EBQ27324064-448CF6ED-BDEF-4E5C-8457-007E8B86EBC4Q28072056-EADCB6C9-E847-4E3E-89FA-C488C5012598Q31143315-6153CFA3-0E2E-4A41-A8E5-7E11BD991B46Q33599411-CFB120AA-F610-4AED-B69C-0EBE6B8D648FQ33619253-365DD912-2E12-45F9-ADB0-1A206B2C2ED3Q33687612-B58D5833-3EB7-48F7-AE77-4A4A6A051696Q33829653-B1BDC717-0E22-4122-ADA9-5B15F75D6208Q33938990-3E246E2E-BF45-4280-8F7A-19911C6F882CQ33962488-7CFEDCB9-2138-4FD8-9FBE-8C0A178E2F38Q34389043-FDF0C013-93B4-462E-A224-8B275ECD9528Q34793505-3D3A50AF-B787-4974-80F8-4785588BC89EQ34956879-21A9E7E8-B125-4C30-B17C-000C02F22049Q35076442-E2AA1B80-A302-4545-8D32-9E111539FD3CQ35234273-CDF9776E-8368-46C6-8CD3-956E4EACEEA0Q35741699-072C650E-7CA5-4901-82E5-0CCD58DC5ADFQ35799542-492A7320-8774-4B49-8F48-5B939F05C43EQ36375224-9D7D4A8A-45C7-4B6B-A689-6D629FE3C931Q36544974-9E744FB0-304E-408C-A1C5-DC43EE8BA865Q36657633-75A58F6B-C265-4E0E-86AA-F3C0E2FBDD8CQ36702568-9C9E65C4-84B3-4499-836A-D4209940034FQ36759439-780BD728-81B1-4188-BD8F-C3B4284F1F15Q36764848-93D08034-49B8-455F-A32B-745276B6F49EQ36814884-5D1588FF-467A-4697-9E78-C46661F322C1Q36963792-BBF9BEEF-58B4-4658-A9D4-A266AFFB4AF7Q37109724-B14CB97A-A8FD-4F50-A9FA-303F853BD054Q37301794-2E72C40F-1B51-4791-9929-760629266578Q37326689-20F78D39-B82E-4D67-A50B-22B679546B8EQ37392616-B7C4EF70-B3BB-4837-8FCC-AC2433A5B2B1Q37393451-D3611C61-713B-48E3-93A1-84B002CB14A6Q37583296-CBE3F55C-5C2B-4F04-A91D-E4E3B709C864Q37681322-59983C74-AC01-4532-A0AD-B598473EB224Q37697488-01DCA3FE-DC16-44CE-B6B3-7CE73AA8ED01Q37718061-9BB30716-A446-46A9-84A0-FA6C2A5312F1Q38189850-B63C715F-C9D2-4762-B154-A353CF1A09D3Q38783321-12805893-A901-49E0-A3BA-F0A17539FC80Q38814178-B8048661-9A76-4913-BBDC-FC0AC4983EFAQ38926686-7C429355-5B2B-47B8-837C-828874516A0CQ38971233-11FA5EC8-8147-4B8F-84E3-50A1128DC13E
P2860
miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
miR-134 inhibits epithelial to ...... -small cell lung cancer cells.
@en
miR-134 inhibits epithelial to ...... -small cell lung cancer cells.
@nl
type
label
miR-134 inhibits epithelial to ...... -small cell lung cancer cells.
@en
miR-134 inhibits epithelial to ...... -small cell lung cancer cells.
@nl
prefLabel
miR-134 inhibits epithelial to ...... -small cell lung cancer cells.
@en
miR-134 inhibits epithelial to ...... -small cell lung cancer cells.
@nl
P2093
P2860
P1433
P1476
miR-134 inhibits epithelial to ...... -small cell lung cancer cells.
@en
P2093
Jianfei Ying
Jianping Luo
Yanhong Yu
Yiping Wang
Zhongming Fu
P2860
P304
P356
10.1016/J.FEBSLET.2012.09.016
P407
P577
2012-09-23T00:00:00Z